DRIVE-AB To Tackle Policy Problem Of Near Empty Pipeline Of New Antibiotics

We never miss pharmaceutical companies until they are gone.Lawsuits, terrifically expensive drug development cycles and trials coupled with a short window for sales before a drug is declared out of patent and therefore generic has meant companies are abandoning markets that are not lucrative, like antibiotics. Critics who believed drug companies were evil and greedy have found that government is incapable of doing applied research - and that is leaving a huge void. read more

Read the whole article on

More from